Physician profile
Danielle Wehle
NPI 1154340610
$2,648.69
in general payments reported to CMS, 2019-2025
13 companies · $420 in 2025
The $420 reported for 2025 was more than what 88% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $138 · 2021: $316 · 2022: $393 · 2023: $159 · 2024: $874 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $928 · Gift: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $927.54 |
| Gift | $525.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $1,007.36 | 2019-2025 | |
| Align Technology, INC. | $832.62 | 2019-2025 | Invisalign, Invisalign System - Moderate |
| Dentalez, INC. | $525.41 | 2024 | Lf Turbine |
| Dentsply Sirona INC | $62.98 | 2023-2025 | Suresmile, Cavitron, Q-Mix |
| Solventum Corporation | $41.47 | 2025 | 3m Espe Filtek Supreme Ultra Universal Restorative |
| Kerr Corporation | $37.43 | 2019 | |
| Crosstex International INC. | $32.01 | 2019 | |
| Tulsa Dental Products LLC | $29.90 | 2019 | |
| Dexcel Pharma Technologies LTD. | $19.89 | 2019 | |
| Orapharma, A Division of Bausch Health US, LLC | $18.15 | 2023 | Arestin |
| Henry Schein, INC. | $17.11 | 2019 | |
| Gc America INC. | $13.56 | 2024 | G-Premio Bond, Everstick, G-Aenial |
| Nobel Biocare USA | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Wehle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.